We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intel, Edwards Lifesciences Top Q1 Earnings Estimates
Read MoreHide Full Article
Intel Corp. (INTC - Free Report) , a Zacks Rank #3 (Hold)-rated company prior to its Q1 earnings report after Thursday’s closing bell, easily outpaced estimates on both top and bottom lines. Earnings of $1.45 per share was well ahead of both the $1.28 expected and the 89 cents per share reported in the year-ago quarter. Revenues in the quarter reached $19.83 billion, higher than the $18.75 billion in the Zacks consensus.
PC-related businesses brought in $9.8 billion in Q1, higher than the $9.3 billion analysts were looking for. Intel’s Data Center finished the quarter with $7 billion in sales, ahead of the $6.3 billion estimate. The company has clearly shown its strength as a “work from home” stock, which has justified its 19% stock gain in the past month. Intel has not missed a quarterly earnings estimate since Q4 2013.
That said, we appear to be seeing a “sell the news” scenario with regard to Intel stock, as shares are down 5% upon the earnings release. The company also suspended guidance for its full-year earnings and revenues, while the company guided slightly lower for Q2 2020. For more on INTC’s earnings, click here.
Edwards Lifesciences (EW - Free Report) , another Zacks Rank #3 stock, also outperformed expectations after regular trading ended, with $1.51 per share rocketing past the $1.29 expected and +14% year over year. Sales of $1.1 billion surpassed the $1.05 billion analysts were anticipating. Revenues guidance for next quarter provided a range of $700-900 million, where the Zacks consensus estimate of $821.72 million rests easily.
In this 300-page hardcover, Zacks' Executive VP Kevin Matras reveals almost every stock-picking secret he’s learned from the system that since 1988 has more than doubled the average yearly gain of the S&P 500.
Learn more now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intel, Edwards Lifesciences Top Q1 Earnings Estimates
Intel Corp. (INTC - Free Report) , a Zacks Rank #3 (Hold)-rated company prior to its Q1 earnings report after Thursday’s closing bell, easily outpaced estimates on both top and bottom lines. Earnings of $1.45 per share was well ahead of both the $1.28 expected and the 89 cents per share reported in the year-ago quarter. Revenues in the quarter reached $19.83 billion, higher than the $18.75 billion in the Zacks consensus.
PC-related businesses brought in $9.8 billion in Q1, higher than the $9.3 billion analysts were looking for. Intel’s Data Center finished the quarter with $7 billion in sales, ahead of the $6.3 billion estimate. The company has clearly shown its strength as a “work from home” stock, which has justified its 19% stock gain in the past month. Intel has not missed a quarterly earnings estimate since Q4 2013.
That said, we appear to be seeing a “sell the news” scenario with regard to Intel stock, as shares are down 5% upon the earnings release. The company also suspended guidance for its full-year earnings and revenues, while the company guided slightly lower for Q2 2020. For more on INTC’s earnings, click here.
Edwards Lifesciences (EW - Free Report) , another Zacks Rank #3 stock, also outperformed expectations after regular trading ended, with $1.51 per share rocketing past the $1.29 expected and +14% year over year. Sales of $1.1 billion surpassed the $1.05 billion analysts were anticipating. Revenues guidance for next quarter provided a range of $700-900 million, where the Zacks consensus estimate of $821.72 million rests easily.
Full-year guidance, however, was lowered from the previous $4.6-5.0 billion to an updated $4.0-4.5 billion. For more on EW’s earnings, click here.
Free Book: Finding #1 Stocks
In this 300-page hardcover, Zacks' Executive VP Kevin Matras reveals almost every stock-picking secret he’s learned from the system that since 1988 has more than doubled the average yearly gain of the S&P 500.
Learn more now >>